Evidence map›Paper›PMID 33526799›Full record

ArticleScientific reports2021

Alterations in cellular and organellar phospholipid compositions of HepG2 cells during cell growth.

Tokuji Tsuji, Shin-Ya Morita, Yoshinobu Nakamura, Yoshito Ikeda, Taiho Kambe, Tomohiro Terada

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Phospholipid biomarkers of coronary heart disease.Journal of pharmaceutical health care and sciences · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tokuji TsujiDepartment of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Shiga, 520-2192, Japan.
Shin-Ya MoritaDepartment of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Shiga, 520-2192, Japan. smorita@belle.shiga-med.ac.jp.
Yoshinobu NakamuraDepartment of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Shiga, 520-2192, Japan.
Yoshito IkedaDepartment of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Shiga, 520-2192, Japan.
Taiho KambeGraduate School of Biostudies, Kyoto University, Kyoto, 606-8502, Japan.
Tomohiro TeradaDepartment of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Shiga, 520-2192, Japan.
Shiga University of Medical Science Hospital · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human hepatoblastoma cell line, HepG2, has been used for investigating a wide variety of physiological and pathophysiological processes. However, less information is available about the phospholipid metabolism in HepG2 cells. In the present report, to clarify the relationship between cell growth and phospholipid metabolism in HepG2 cells, we examined the phospholipid class compositions of the cells and their intracellular organelles by using enzymatic fluorometric methods. In HepG2 cells, the ratios of all phospholipid classes, but not the ratio of cholesterol, markedly changed with cell growth. Of note, depending on cell growth, the phosphatidic acid (PA) ratio increased and phosphatidylcholine (PC) ratio decreased in the nuclear membranes, the sphingomyelin (SM) ratio increased in the microsomal membranes, and the phosphatidylethanolamine (PE) ratio increased and the phosphatidylserine (PS) ratio decreased in the mitochondrial membranes. Moreover, the mRNA expression levels of enzymes related to PC, PE, PS, PA, SM and cardiolipin syntheses changed during cell growth. We suggest that the phospholipid class compositions of organellar membranes are tightly regulated by cell growth. These findings provide a basis for future investigations of cancer cell growth and lipid metabolism.

Indexed as

Cell MembraneCell ProliferationHep G2 CellsHumansLipid MetabolismOrganellesPhosphatidylcholinesPhosphatidylserinesPhospholipidsPhosphatidylcholinesPhosphatidylserinesPhospholipids

Identifiers

PMID33526799
PMCPMC7851136
OpenAlexW3126155810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.